相似文献
1
Association study of four key folliculogenesis genes in polycystic ovary syndrome.
BJOG. 2010 May;117(6):756-60. doi: 10.1111/j.1471-0528.2010.02527.x. Epub 2010 Mar 12.
2
The role of AMH and its receptor SNP in the pathogenesis of PCOS.
Mol Cell Endocrinol. 2017 Jan 5;439:363-368. doi: 10.1016/j.mce.2016.09.023. Epub 2016 Sep 21.
3
Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
J Assist Reprod Genet. 2016 Feb;33(2):199-205. doi: 10.1007/s10815-015-0641-9. Epub 2016 Jan 6.
4
Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
J Clin Endocrinol Metab. 2013 Nov;98(11):E1866-70. doi: 10.1210/jc.2013-2458. Epub 2013 Aug 22.
5
Genes involved in initial follicle recruitment may be associated with age at menopause.
J Clin Endocrinol Metab. 2011 Mar;96(3):E473-9. doi: 10.1210/jc.2010-1799. Epub 2010 Dec 30.
6
Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2855-2874. doi: 10.1210/jc.2018-02178.
7
Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
J Assist Reprod Genet. 2019 Jun;36(6):1281-1289. doi: 10.1007/s10815-019-01472-3. Epub 2019 May 14.
8
Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.
Cell Physiol Biochem. 2016;39(6):2249-2261. doi: 10.1159/000447918. Epub 2016 Nov 7.
9
Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.
Endocrine. 2015 Apr;48(3):1001-4. doi: 10.1007/s12020-014-0345-4. Epub 2014 Jul 11.
10
Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3970-3978. doi: 10.1210/jc.2017-00308.
引用本文的文献
1
Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors.
World J Diabetes. 2025 Jul 15;16(7):108789. doi: 10.4239/wjd.v16.i7.108789.
2
GDF9 and GDF9 bi-allelic variants caused female subfertility with defective follicle enlargement.
Cell Commun Signal. 2024 Apr 20;22(1):235. doi: 10.1186/s12964-024-01616-8.
3
Chamomile and Urtica dioica extracts improve immunological and histological alterations associated with polycystic ovarian syndrome in DHEA -induced mice.
BMC Complement Med Ther. 2023 Apr 3;23(1):102. doi: 10.1186/s12906-023-03936-7.
4
Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM.
Reprod Biol Endocrinol. 2022 Aug 19;20(1):126. doi: 10.1186/s12958-022-01000-6.
5
Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3374-e3383. doi: 10.1210/clinem/dgac272.
6
DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
Technol Health Care. 2021;29(S1):11-25. doi: 10.3233/THC-218002.
7
Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
Front Endocrinol (Lausanne). 2020 Sep 9;11:641. doi: 10.3389/fendo.2020.00641. eCollection 2020.
8
The transcriptional regulator CBX2 and ovarian function: A whole genome and whole transcriptome approach.
Sci Rep. 2019 Nov 19;9(1):17033. doi: 10.1038/s41598-019-53370-4.
9
Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function.
Vitam Horm. 2018;107:317-348. doi: 10.1016/bs.vh.2017.12.003.
10
Mutation analysis of exon1 of bone morphogenetic protein-15 gene in Iranian patients with polycystic ovarian syndrome.
Int J Reprod Biomed. 2016 Aug;14(8):527-32.
本文引用的文献
1
Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome.
J Clin Endocrinol Metab. 2008 Nov;93(11):4456-61. doi: 10.1210/jc.2008-1231. Epub 2008 Aug 12.
2
A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
J Clin Endocrinol Metab. 2008 Apr;93(4):1310-6. doi: 10.1210/jc.2007-2205. Epub 2008 Jan 29.
3
Association of genetic markers within the BMP15 gene with anovulation and infertility in women with polycystic ovary syndrome.
Fertil Steril. 2008 Aug;90(2):447-9. doi: 10.1016/j.fertnstert.2007.06.083. Epub 2007 Oct 1.
4
Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.
J Clin Endocrinol Metab. 2007 Jan;92(1):240-5. doi: 10.1210/jc.2006-1582. Epub 2006 Oct 24.
5
Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
J Clin Endocrinol Metab. 2005 Oct;90(10):5536-43. doi: 10.1210/jc.2005-0907. Epub 2005 Jul 19.
6
Haploview: analysis and visualization of LD and haplotype maps.
Bioinformatics. 2005 Jan 15;21(2):263-5. doi: 10.1093/bioinformatics/bth457. Epub 2004 Aug 5.
7
The prevalence and features of the polycystic ovary syndrome in an unselected population.
J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9. doi: 10.1210/jc.2003-032046.
8
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome.
J Clin Endocrinol Metab. 2002 Mar;87(3):1337-44. doi: 10.1210/jcem.87.3.8316.
9
Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.
Mol Endocrinol. 2001 Jun;15(6):854-66. doi: 10.1210/mend.15.6.0662.
10
Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome.
Fertil Steril. 2000 Nov;74(5):976-9. doi: 10.1016/s0015-0282(00)01539-9.
Zotero 插件